Bayer Unit Sues Generics Maker Over Acne Treatment

By Megan Stride

Law360, New York (September 02, 2010, 1:40 PM ET) -- Bayer HealthCare AG unit Intendis Inc. has accused River's Edge Pharmaceuticals LLC of issuing false statements about a prescription acne medication and inaccurately passing it off as a generic version of the plaintiff's competing treatment.

Intendis lodged a complaint in the U.S. District Court for the District of Maryland on Wednesday, accusing River's Edge and its subsidiary Kylemore Pharmaceuticals LLC of deceptive advertising and unfair trade under the Lanham Act.

According to the suit, River's Edge and Kylemore have disseminated false information to the marketplace regarding...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles